Evidence map›Paper›PMID 30386852›Full record

ArticleJAMIA open2018

Design and implementation of pragmatic clinical trials using the electronic medical record and an adaptive design.

Kelly Claire Simon, Samuel Tideman, Laura Hillman, Rebekah Lai, Raman Jathar, Yuan Ji, Stuart Bergman-Bock, James Castle, Tiffani Franada, Thomas Freedom and 11 more

Abstract read
In one paragraph

Article in JAMIA open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. A methodological review of pragmatic designs in acute stroke trials.International journal of stroke : official journal of the International Stroke Society · 2026
    Review
  3. Use of EpicClinical trials (London, England) · 2025
    Article
  4. Automatic Population of the Case Report Forms for an International Multifactorial Adaptive Platform Trial Amid the COVID-19 Pandemic.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  5. Article
  6. Innovative trial design in precision oncology.Seminars in cancer biology · 2022
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kelly Claire SimonNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Samuel TidemanClinical Analytics, NorthShore University Health System, Evanston, Illinois, USA.
Laura HillmanHealth Information Technology, NorthShore University Health System, Evanston, Illinois, USA.
Rebekah LaiHealth Information Technology, NorthShore University Health System, Evanston, Illinois, USA.
Raman JatharHealth Information Technology, NorthShore University Health System, Evanston, Illinois, USA.
Yuan JiResearch Institute, NorthShore University Health System, Evanston, Illinois, USA.
Stuart Bergman-BockNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
James CastleNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Tiffani FranadaNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Thomas FreedomNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Revital MarcusNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Angela MarkNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Steven MeyersNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Susan RubinNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Irene SemenovNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Chad YucusNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Anna PhamNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Lisette GardunoNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Monika SzelaNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Roberta FrigerioNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.
Demetrius M MaraganoreNorthshore Neurological Institute, NorthShore University Health System, Evanston, Illinois, USA.

Funding

The Institute for Translational MedicineUL1TR002389 · NCATS · UNIVERSITY OF CHICAGO · PI Joshua J Jacobs, DAVID O MELTZER · 2017 to 2026
$71.6M
Quality Improvement and Practice Based Research in Neurology Using the EMRR01HS024057 · AHRQ · UNIVERSITY OF FLORIDA · PI MARAGANORE, DEMETRIUS MICHAEL · 2015 to 2019
$1.1M
AHRQ HHS R01 HS024057NCATS NIH HHS UL1 TR002389
6 · The paper itself

Abstract

objectivesTo demonstrate the feasibility of pragmatic clinical trials comparing the effectiveness of treatments using the electronic medical record (EMR) and an adaptive assignment design.

methodsWe have designed and are implementing pragmatic trials at the point-of-care using custom-designed structured clinical documentation support and clinical decision support tools within our physician's typical EMR workflow. We are applying a subgroup based adaptive design (SUBA) that enriches treatment assignments based on baseline characteristics and prior outcomes. SUBA uses information from a randomization phase (phase 1, equal randomization, 120 patients), to adaptively assign treatments to the remaining participants (at least 300 additional patients total) based on a Bayesian hierarchical model. Enrollment in phase 1 is underway in our neurology clinical practices for 2 separate trials using this method, for migraine and mild cognitive impairment (MCI).

resultsWe are successfully collecting structured data, in the context of the providers' clinical workflow, necessary to conduct our trials. We are currently enrolling patients in 2 point-of-care trials of non-inferior treatments. As of March 1, 2018, we have enrolled 36% of eligible patients into our migraine study and 63% of eligible patients into our MCI study. Enrollment is ongoing and validation of outcomes has begun. DISCUSSION: This proof of concept article demonstrates the feasibility of conducting pragmatic trials using the EMR and an adaptive design.

conclusionThe demonstration of successful pragmatic clinical trials based on a customized EMR and adaptive design is an important next step in achieving personalized medicine and provides a framework for future studies of comparative effectiveness.

Indexed as

clinical decision supportelectronic medical recordspragmatic clinical trialsprecision medicinesub-group based adaptive designs

Identifiers

PMID30386852
PMCPMC6207187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.